NCT00114387View on ClinicalTrials.gov

VEAPS: Vitamin E Atherosclerosis Prevention Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

353

Participants

Timeline

Start Date

July 31, 1996

Primary Completion Date

September 30, 2000

Study Completion Date

September 30, 2000

Conditions
Atherosclerosis
Interventions
DRUG

DL-alpha-tocopherol

Trial Locations (1)

90033

Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine, Los Angeles

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

National Institute on Aging (NIA)

NIH

NCT00114387 - VEAPS: Vitamin E Atherosclerosis Prevention Study | Biotech Hunter | Biotech Hunter